For: |
Li Y, Shang P, Qian AR, Wang L, Yang Y, Chen ZN. Inhibitory effects of antisense RNA of HAb18G/CD147 on invasion of hepatocellular carcinoma cells |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v9/i10/2174.htm |
Number | Citing Articles |
1 |
Dhivya Kumar, Umashankar Vetrivel, Sowmya Parameswaran, Krishna Kumar Subramanian. Structural insights on druggable hotspots in CD147: A bull's eye view. Life Sciences 2019; 224: 76 doi: 10.1016/j.lfs.2019.03.044
|
2 |
Wei‐de Zhong, Yu‐xiang Liang, Sharron X. Lin, Ling Li, Hui‐chan He, Xue‐cheng Bi, Zhao‐dong Han, Qi‐shan Dai, Yong‐kang Ye, Qing‐biao Chen, Yue‐sheng Wang, Guo‐hua Zeng, Gang Zhu, Zheng Zhang, Zhi‐nan Chen, Chin‐Lee Wu. Expression of CD147 is associated with prostate cancer progression. International Journal of Cancer 2012; 130(2): 300 doi: 10.1002/ijc.25982
|
3 |
Shu Zhao, Wenjie Ma, Minghui Zhang, Dabei Tang, Qingtao Shi, Shanqi Xu, Xiaosan Zhang, Yupeng Liu, Ying Song, Leyuan Liu, Qingyuan Zhang. High expression of CD147 and MMP-9 is correlated with poor prognosis of triple-negative breast cancer (TNBC) patients. Medical Oncology 2013; 30(1) doi: 10.1007/s12032-012-0335-4
|
4 |
I. A. Drachkova, M. V. Lysova, M. N. Repkova, O. V. Prokuda, A. A. Sokolenko, T. V. Arshinova, V. F. Kobzev, V. I. Yamkovoi, L. K. Savinkova. Interaction of RNA polymerase II general transcription complex proteins with oligoribonucleotides. Molecular Biology 2005; 39(1): 123 doi: 10.1007/s11008-005-0017-9
|
5 |
Qin Xu, Mingang Ying, Guilin Chen, Ang Lin, Yunqing Xie, Noriyuki Ohara, Dongmei Zhou. ADAM17 is associated with EMMPRIN and predicts poor prognosis in patients with uterine cervical carcinoma. Tumor Biology 2014; 35(8): 7575 doi: 10.1007/s13277-014-1990-1
|
6 |
MAb V58 Anti-Type XVII Collagen; MAb Against Carp Sperm Creatine Kinase; MAb to FABP4; MAb Against Daintain; MAb Human CacyBP; MAb Against Canine CD45 Homologue; MAb 1B6, 2A11, 6A12, 7E11, and 8A12 Anti-Human Nup62; MAb 1B3, 3B3, HAb18Gedomab1, and HAb18Gedomab2; MAb PHR1 Anti-GARFT; MAb JY/93 Anti-Murine CD72. Hybridoma 2006; 25(3): 163 doi: 10.1089/hyb.2006.25.163
|
7 |
Li Wang, Xiao-Ming Ku, Yu Li, Hui-Jie Bian, Si-He Zhang, Hui Ye, Xi-Ying Yao, Bie-Hu Li, Xiang-Min Yang, Cheng-Gong Liao, Zhi-Nan Chen. Regulation of Matrix Metalloproteinase Production and Tumor Cell Invasion by Four Monoclonal Antibodies Against Different Epitopes of HAb18G/CD147 Extracellular Domain. Hybridoma 2006; 25(2): 60 doi: 10.1089/hyb.2006.25.60
|
8 |
Xuecheng Bi, Huichan He, Yongkang Ye, Qishan Dai, Zhaodong Han, Yunxiang Liang, Weide Zhong. Association of TMPRSS2 and KLK11 gene expression levels with clinical progression of human prostate cancer. Medical Oncology 2010; 27(1): 145 doi: 10.1007/s12032-009-9185-0
|
9 |
Kelly M Kennedy, Mark W Dewhirst. Tumor Metabolism of Lactate: The Influence and Therapeutic Potential for MCT and CD147 Regulation. Future Oncology 2010; 6(1): 127 doi: 10.2217/fon.09.145
|
10 |
Yi-Jun Xue, Qiang Lu, Zhi-Xi Sun. CD147 overexpression is a prognostic factor and a potential therapeutic target in bladder cancer. Medical Oncology 2011; 28(4): 1363 doi: 10.1007/s12032-010-9582-4
|
11 |
Zhao-dong Han, Xue-cheng Bi, Wei-jun Qin, Hui-chan He, Qi-shan Dai, Jun Zou, Yong-kang Ye, Yu-xiang Liang, Guo-hua Zeng, Zhi-nan Chen, Wei-de Zhong. CD147 Expression Indicates Unfavourable Prognosis in Prostate Cancer. Pathology & Oncology Research 2009; 15(3): 369 doi: 10.1007/s12253-008-9131-z
|
12 |
Judy Wai Ping Yam, Edith Yuk Ting Tse, Irene Oi‐Lin Ng. Role and significance of focal adhesion proteins in hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 2009; 24(4): 520 doi: 10.1111/j.1440-1746.2009.05813.x
|
13 |
Hengwei Fan, Wanwan Yi, Chenxing Wang, Jisheng Wang. The clinicopathological significance and prognostic value of EMMPRIN overexpression in cancers: evidence from 39 cohort studies. Oncotarget 2017; 8(47): 82643 doi: 10.18632/oncotarget.19740
|
14 |
Lu Wu, Ye-Fa Yang, Nai-Jian Ge, Shu-Qun Shen, Jun Liang, Yi Wang, Wei-Ping Zhou, Feng Shen, Meng-Chao Wu. Hepatic Arterial Iodine-131–Labeled Metuximab Injection Combined with Chemoembolization for Unresectable Hepatocellular Carcinoma: Interim Safety and Survival Data from 110 Patients. Cancer Biotherapy and Radiopharmaceuticals 2010; 25(6): 657 doi: 10.1089/cbr.2010.0801
|
15 |
Xiaoling Jiang, Charyl M. Dutton, Wen‐ning Qi, Joel A. Block, Nandor Garamszegi, Sean P. Scully. siRNA mediated inhibition of MMP‐1 reduces invasive potential of a human chondrosarcoma cell line. Journal of Cellular Physiology 2005; 202(3): 723 doi: 10.1002/jcp.20162
|
16 |
Wei Zou, Hong Yang, Xianghua Hou, Wei Zhang, Biliang Chen, Xiaoyan Xin. Inhibition of CD147 gene expression via RNA interference reduces tumor cell invasion, tumorigenicity and increases chemosensitivity to paclitaxel in HO-8910pm cells. Cancer Letters 2007; 248(2): 211 doi: 10.1016/j.canlet.2006.07.005
|
17 |
Shaohui Hu, Yu Li, Guozhen Liu, Qifeng Song, Li Wang, Yuning Han, Yang Zhang, Yali Song, Xiying Yao, Yong Tao, Haipan Zeng, Huanming Yang, Jian Wang, Heng Zhu, Zhi‐Nan Chen, Lin Wu. A protein chip approach for high‐throughput antigen identification and characterization. PROTEOMICS 2007; 7(13): 2151 doi: 10.1002/pmic.200600923
|
18 |
Ai-Rong Qian, Wei Zhang, Jian-Ping Cao, Peng-Fei Yang, Xiang Gao, Zhe Wang, Hui-Yun Xu, Yuan-Yuan Weng, Peng Shang. Downregulation of CD147 expression alters cytoskeleton architecture and inhibits gelatinase production and SAPK pathway in human hepatocellular carcinoma cells. Journal of Experimental & Clinical Cancer Research 2008; 27(1) doi: 10.1186/1756-9966-27-50
|
19 |
D.S.R. Lockwood, D.C. Gotley. Integration/Interaction of Oncologic Growth. Cancer Growth and Progression 2005; 15: 165 doi: 10.1007/1-4020-3414-8_9
|
20 |
AiRong Qian, Wei Zhang, YuanYuan Weng, Peng Shang. Stealth siRNA against CD147 inhibits hepatocellular carcinoma cell metastatic properties. Biologia 2008; 63(5): 756 doi: 10.2478/s11756-008-0132-x
|
21 |
Yu Weiwei, Liu Jinhui, Xiong Xiaoliang, Ai Yousheng, Wang Huamin. Expression of MMP9 and CD147 in invasive squamous cell carcinoma of the uterine cervix and their implication. Pathology - Research and Practice 2009; 205(10): 709 doi: 10.1016/j.prp.2009.05.010
|
22 |
Fangfang Liu, Lifang Cui, Yang Zhang, Ling Chen, Yahong Wang, Yu Fan, Ting Lei, Feng Gu, Ronggang Lang, Gordon A. Pringle, Xinmin Zhang, Zhinan Chen, Li Fu. Expression of HAb18G is associated with tumor progression and prognosis of breast carcinoma. Breast Cancer Research and Treatment 2010; 124(3): 677 doi: 10.1007/s10549-010-0790-6
|
23 |
Ling‐Min Kong, Cheng‐Gong Liao, Fei Fei, Xu Guo, Jin‐Liang Xing, Zhi‐Nan Chen. Transcription factor Sp1 regulates expression of cancer‐associated molecule CD147 in human lung cancer. Cancer Science 2010; 101(6): 1463 doi: 10.1111/j.1349-7006.2010.01554.x
|
24 |
JING ZHAO, WEI YE, JUAN WU, LIJUAN LIU, LINA YANG, LU GAO, BILIANG CHEN, FANGLIN ZHANG, HONG YANG, YU LI. Sp1-CD147 positive feedback loop promotes the invasion ability of ovarian cancer. Oncology Reports 2015; 34(1): 67 doi: 10.3892/or.2015.3999
|
25 |
Zhi-Nan Chen, Li Mi, Jing Xu, Fei Song, Qing Zhang, Zheng Zhang, Jin-Liang Xing, Hui-Jie Bian, Jian-Li Jiang, Xian-Hui Wang, Peng Shang, Ai-Rong Qian, Si-He Zhang, Ling Li, Yu Li, Qiang Feng, Xiao-Ling Yu, Yuan Feng, Xiang-Min Yang, Rong Tian, Zhen-Biao Wu, Nan Leng, Ting-Shu Mo, An-Ren Kuang, Tian-Zhi Tan, Yun-Chun Li, De-Rong Liang, Wu-Sheng Lu, Jia Miao, Guo-Hui Xu, Zhi-Hui Zhang, Ke-Jun Nan, Jun Han, Qing-Guang Liu, Hong-Xin Zhang, Ping Zhu. Targeting radioimmunotherapy of hepatocellular carcinoma with iodine (131I) metuximab injection: Clinical Phase I/II trials. International Journal of Radiation Oncology*Biology*Physics 2006; 65(2): 435 doi: 10.1016/j.ijrobp.2005.12.034
|
26 |
Chao-Yang Lou, Ying-Ming Feng, Ai-Rong Qian, Yu Li, Hao Tang, Peng Shang, Zhi-Nan Chen. Establishment and characterization of human hepatocellular carcinoma cell line FHCC-98. World Journal of Gastroenterology 2004; 10(10): 1462-1465 doi: 10.3748/wjg.v10.i10.1462
|
27 |
Lu Wu, Ye-Fa Yang, Nai-Jian Ge, Shu-Qun Shen, Jun Liang, Yi Wang, Wei-Ping Zhou, Feng Shen, Meng-Chao Wu. Hepatic artery injection of 131I-labelled metuximab combined with chemoembolization for intermediate hepatocellular carcinoma: a prospective nonrandomized study. European Journal of Nuclear Medicine and Molecular Imaging 2012; 39(8): 1306 doi: 10.1007/s00259-012-2145-5
|
28 |
MAb V58 Anti-Type XVII Collagen; MAb Against Carp Sperm Creatine Kinase; MAb to FABP4; MAb Against Daintain; MAb Human CacyBP; MAb Against Canine CD45 Homologue; MAb 1B6, 2A11, 6A12, 7E11, and 8A12 Anti-Human Nup62; MAb 1B3, 3B3, HAb18Gedomab1, and HAb18Gedomab2; MAb PHR1 Anti-GARFT; MAb JY/93 Anti-Murine CD72. Hybridoma 2006; 25(3): 168 doi: 10.1089/hyb.2006.25.168
|
29 |
Yuan Wang, Lin Yuan, Xiang-Min Yang, Ding Wei, Bin Wang, Xiu-Xuan Sun, Fei Feng, Gang Nan, Ye Wang, Zhi-Nan Chen, Huijie Bian. A chimeric antibody targeting CD147 inhibits hepatocellular carcinoma cell motility via FAK-PI3K-Akt-Girdin signaling pathway. Clinical & Experimental Metastasis 2015; 32(1): 39 doi: 10.1007/s10585-014-9689-7
|
30 |
Yu Li, Jing Xu, Li Chen, Wei‐De Zhong, Zheng Zhang, Li Mi, Yang Zhang, Cheng‐Gong Liao, Hui‐Jie Bian, Jian‐Li Jiang, Xiang‐Min Yang, Xiao‐Yan Li, Chun‐Mei Fan, Ping Zhu, Li Fu, Zhi‐Nan Chen. HAb18G (CD147), a cancer‐associated biomarker and its role in cancer detection. Histopathology 2009; 54(6): 677 doi: 10.1111/j.1365-2559.2009.03280.x
|
31 |
Wei-De Zhong, Qing-Biao Chen, Yong-Kang Ye, Zhao-Dong Han, Xue-Cheng Bi, Qi-Shan Dai, Yu-xiang Liang, Guo-Hua Zeng, Yue-Sheng Wang, Gang Zhu, Zhi-Nan Chen, Hui-Chan He. Extracellular matrix metalloproteinase inducer expression has an impact on survival in human bladder cancer. Cancer Epidemiology 2010; 34(4): 478 doi: 10.1016/j.canep.2010.04.007
|